A new risk factor for neonatal vancomycin-resistant Enterococcus colonisation: Bacterial probiotics

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 28, Issue 12, 2015, Pages 1491-1494

  Topcuoglu, Sevilay ^a   Gursoy, Tugba ^a   Ovali, Fahri ^a   Serce, Ozge ^a   Karatekin, Guner ^a  

^a Zeynep Kamil Maternity and Child Research and Training Hospital   (Turkey)

Author keywords

Newborn; probiotics; vancomycin resistant Enterococcus

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; LACTOFERRIN; PROBIOTIC AGENT; VANCOMYCIN; GALACTOSE; OLIGOSACCHARIDE;

ARTICLE; BACTERIAL COLONIZATION; BIFIDOBACTERIUM ANIMALIS; COLOSTRUM; CONTROLLED STUDY; FEMALE; HOSPITAL DISCHARGE; HUMAN; INFANT; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; VANCOMYCIN RESISTANT ENTEROCOCCUS; BIFIDOBACTERIUM; CROSS INFECTION; EPIDEMIC; GESTATIONAL AGE; GROWTH, DEVELOPMENT AND AGING; INFECTION CONTROL; LACTOBACILLUS; MICROBIOLOGY; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; TURKEY;

BIFIDOBACTERIUM; CROSS INFECTION; DISEASE OUTBREAKS; GALACTOSE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFECTION CONTROL; LACTOBACILLUS; OLIGOSACCHARIDES; PROBIOTICS; RISK FACTORS; TURKEY; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84940746753     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.958462     Document Type: Article

References (25)

1. Yüce A, Karaman M, Gülay Z, Yulug N. Vancomycin-resistant enterococci in neonates. Scand J Infect Dis 2001;33:803-5.
2. Hufnagel M, Liese C, Loescher C, et al. Enterococcal colonization of infants in a neonatal intensive care unit: associated predictors, risk factors and seasonal patterns. BMC Infect Dis 2007;7:107.
3. Benzer D, Yavuzcan Öztürk D, Gürsoy T, et al. Vancomycin-resistant enterococcus colonization in neonatal intensive care unit: prevention and eradication experience. Mikrobiyol Bul 2012;46:682-8.
4. Chavers LS, Moser SA, Funkhouser E, et al. Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci. Microb Drug Resist 2003;9:69-77.
5. Zirakzadeh A, Patel R. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc 2006;81:529-36.
6. Biavasco F, Giovanetti E, Miele A, et al. In vitro conjugative transfer of VanA vancomycin resistance between Enterococci and Listeriae of different species. Eur J Clin Microbiol Infect Dis 1996;15:50-9.
7. Zhu W, Murray PR, Huskins WC, et al. Dissemination of an Enterococcus Inc18-Like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2010;54:4314-20.
8. Devirgiliis C, Zinno P, Perozzi G. Update on antibiotic resistance in foodborne Lactobacillus and Lactococcus species. Front Microbiol 2013;4:1-13.
9. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011;3:CD005496.
10. Mathur S, Singh R. Antibiotic resistance in food lactic acid bacteria - a review. Int J Food Microbiol 2005;105:281-95.
11. Devirgiliis C, Barile S, Perozzi G. Antibiotic resistance determinants in the interplay between food and gut microbiota. Genes Nutr 2011;6:275-84.
12. Mater DD, Langella P, Corthier G, Flores MJ. A probiotic Lactobacillus strain can acquire vancomycin resistance during digestive transit in mice. J Mol Microbiol Biotechnol 2008;14:123-7.
13. Feld L, Schjørring S, Hammer K, et al. Selective pressure affects transfer and establishment of a Lactobacillus plantarum resistance plasmid in the gastrointestinal environment. J Antimicrob Chemother 2008;61:845-52.
14. Moubareck C, Bourgeois N, Courvalin P, Doucet-Populaire F. Multiple antibiotic resistance gene transfer from animal to human enterococci in the digestive tract of gnotobiotic mice. Antimicrob Agents Chemother 2003;47:2993-6.
15. Domingo MC, Huletsky A, Giroux R, et al. High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora. Antimicrob Agents Chemother 2005;49:4784-6.
16. Guardabassi L, Christensen H, Hasman H, Dalsgaard A. Members of the genera Paenibacillus and Rhodococcus harbor genes homologous to enterococcal glycopeptide resistance genes vanA and vanB. Antimicrob Agents Chemother 2004;48:4915-18.
17. Werner G, Freitas AR, Coque TM, et al. Host range of enterococcal vanA plasmids among Gram-positive intestinal bacteria. J Antimicrob Chemother 2011;66:273-82.
18. Dionisio F, Matic I, Radman M, et al. Plasmids spread very fast in heterogeneous bacterial communities. Genetics 2002;162:1525-32.
19. Dahl KH, Mater DD, Flores MJ, et al. Transfer of plasmid and chromosomal glycopeptide resistance determinants occurs more readily in the digestive tract of mice than in vitro and exconjugants can persist stably in vivo in the absence of glycopeptide selection. J Antimicrob Chemother 2007;59:478-86.
20. Lester CH, Frimodt-Møller N, Sørensen TL, et al. In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers. Antimicrob Agents Chemother 2006;50:596-9.
21. Iosifidis E, Evdoridou I, Agakidou E, et al. Vancomycin-resistant Enterococcus outbreak in a neonatal intensive care unit:epidemiology, molecular analysis and risk factors. Am J Infect Control 2013;41:857-61.
22. Kritsotakis EI, Christidou A, Roumbelaki M, et al. The dynamic relationship between antibiotic use and the incidence of vancomycin-resistant Enterococcus: time-series modelling of 7-year surveillance data in a tertiary-care hospital. Clin Microbiol Infect 2008;14:747-54.
23. de Bruin MA, Riley LW. Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review. BMC Infect Dis 2007;7:24.
24. Malik RK, Montecalvo MA, Reale MR, et al. Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit. Pediatr Infect Dis J 1999;18:352-6.
25. Ergaz Z, Arad I, Bar-Oz B, et al. Elimination of vancomycin-resistant enterococci from a neonatal intensive care unit following an outbreak. J Hosp Infect 2010;74:370-6.